ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways. [electronic resource]
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology 12 2019
- 14825-14840 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1530-6860
10.1096/fj.201901440RR doi
AMP-Activated Protein Kinase Kinases Adenosine Triphosphate--metabolism Adult Animals Cell Line Cells, Cultured Diabetes Mellitus, Type 2--drug therapy Glucose--metabolism Humans Hypoglycemic Agents--therapeutic use Male Mice Mice, Inbred C57BL Myoblasts--metabolism Protein Kinases--metabolism Proteins--genetics Proto-Oncogene Proteins c-akt--metabolism Recombinant Proteins--therapeutic use ATPase Inhibitory Protein